Oncology ImagingArchives
Ultrasound-based radiomics model for predicting axillary lymph node metastasis of breast cancer
Oncology Imaging 6 min.
Breast cancer has surpassed lung cancer as the most common malignancy worldwide. According to statistics from the world health organization in 2020, there were approximately 2.3 million newly diagnosed female breast cancer patients globally, with around 690,000 deaths [1]. In breast cancer patients,...
Deep learning and radiomics integration of photoacoustic/ultrasound imaging for non-invasive prediction of luminal and non-luminal breast cancer subtypes
Oncology Imaging 7 min.
Breast cancer (BC) is one of the most common malignant tumors and a leading cause of cancer-related mortality among women worldwide, with its incidence rising steadily in recent years [1, 2–3]. As a biologically heterogeneous disease, BC is classified into distinct molecular subtypes, each with...
Relation knowledge distillation 3D-ResNet-based deep learning for breast cancer molecular subtypes prediction on ultrasound videos: a multicenter study
Oncology Imaging 7 min.
Breast cancer is the leading cause of cancer-related death in women worldwide and is a heterogeneous disease comprising intrinsic molecular subtypes associated with varying biological behaviors, treatment strategies, and prognosis [1]. St. Gallen guidelines classify it into four molecular subtypes: Luminal...
Differentiating pancreatic from periampullary non-pancreatic cancer: a nomogram-based prediction model utilizing CT imaging
Oncology Imaging 5 min.
Periampullary carcinomas encompass four main types: ampullary cancer, distal cholangiocarcinoma, pancreatic head cancer, and duodenal cancer [1]. Pancreatoduodenectomy is typically performed for both pancreatic cancer and non-pancreatic periampullary cancers (i.e. distal cholangiocarcinoma, ampullary...
A study on predicting recurrence of non-muscle-invasive bladder cancer within 2 years using mp-MRI radiomics
Oncology Imaging 5 min.
By 2023, Bladder Caner (BCa) is the fourth most common cancer in men, accounting for 6% of estimated new cancers and 4% of cancer-related deaths. Globally, more than 500,000 new diagnoses and approximately 200,000 deaths are reported annually [1, 2]. At the time of initial diagnosis, 70–75% of...
